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Malaria congenital infection constitutes a major risk in malaria endemic areas. In this study, we report the prevalence of
transplacental malaria in Burkina Faso. In labour and delivery units, thick and thin blood ﬁlms were made from maternal,
placental, and umbilical cord blood to determine malaria infection. A total of 1,309 mother/baby pairs were recruited. Eighteen
cord blood samples (1.4%) contained malaria parasites (Plasmodium falciparum). Out of the 369 (28.2%) women with peripheral
positive parasitemia, 211 (57.2%) had placental malaria and 14 (3.8%) had malaria parasites in their umbilical cord blood. The
umbilical cord parasitemia levels were statistically associated with the presence of maternal peripheral parasitemia (OR = 9.24,
P   0.001), placental parasitemia (OR = 10.74, P   0.001), high-density peripheral parasitemia (OR = 9.62, P   0.001), and
high-density placental parasitemia (OR = 4.91, P = 0.03). In Burkina Faso, the mother-to-child transmission rate of malaria
appears to be low.
1.Introduction
In malaria high-transmission areas, some population groups
are at considerably higher risk of infection with Plasmodium
falciparumanddevelopmentofmalariamorbidityormortal-
ity than others. These include children less than ﬁve years of
age and pregnant women. Malaria contributes signiﬁcantly
to perinatal disease burden in terms of pregnancy loss,
prematurity due to preterm labor, and intrauterine growth
retardation [1]. Malaria infection during pregnancy poses a
substantial risk to the mother, her fetus, and the neonate. In
areas of stable malaria transmission such as Burkina Faso,
where adult women have considerable acquired immunity,
Plasmodium falciparum infection during pregnancy does
not cause symptomatic malaria, but may lead to maternal
anemia as well as placental and cord blood malaria infection,
especially among primigravidae and secundigravida [2–4].
Placental malaria is deﬁned as the accumulation of
Plasmodium-infectederythrocytesintheintervillousspacein
the placenta, causing histologic changes including leukocyte-
induced damage to the trophoblastic basement membrane.
The placental infection does not reﬂect the existence of
peripheral infection over a short period preceding the deliv-
ery or whether it is related to infection during pregnancy.
Susceptibility to this may be correlated to high exposure
to malaria and repeated episodes of parasitemia during the
pregnancy [5].
Vertical transmission of malaria from mother to foetus
through the placenta and umbilical cord is deﬁned as umbil-
ical cord blood parasitemia. The transplacental transmission
of Plasmodium falciparum from mother to fetus has long
been well-described [6, 7].
The direct burden of neonatal malaria infection in terms
of prevalence is not well-described in malaria endemic areas.
In fact, the method used to identify congenital transmission
is peripheral blood of newborns or umbilical cord blood.
Malaria parasites have been detected only rarely in the
peripheral blood of newborns, whether the blood specimen2 Journal of Tropical Medicine
iscollectedatthetimeofbirthorhourslater[8,9].Instudies
in which both umbilical cord blood and infant peripheral
blood were obtained at the time of birth, the parasite load
in the babies’ peripheral blood has always been lower than
that in the umbilical cord blood [9–11].
Studies published so far have documented contradictory
levels of this burden. In countries without endemic malaria,
congenital malaria has occurred in children born to women
who have immigrated from malarious areas. However,
transplacental transmission of Plasmodium falciparum has
been found to be rare in malaria-endemic areas, ranging
from about 1 to 5% [12–15]. In contrast, data from recent
studies on the burden of congenital and neonatal malaria,
while scarce and contradictory, have indicated a high burden
(more than 15%) in parts of sub-Saharan Africa [13, 15–18].
InBurkinaFaso,therealprevalenceofneonatalmalariais
unknown but is estimated to be even higher. This assessment
isbasedonpresumptivemalariadiagnosis.Thepresentstudy
was designed to determine the real burden of transplacental
transmission, the risk factors associated with transplacental
transmission, and the prevalence of cord blood and placental
malaria parasitemia in malaria holoendemic area of Burkina
Faso.
These results represent a pooled analysis of studies on
malariapreventioninpregnantwomen[4,19,20]examining
umbilical cord blood to determine the frequency of transpla-
cental transmission of Plasmodium falciparum.
2.MaterialsandMethods
2.1. Study Site. The ﬁrst study took place within six delivery
units (DUs) of the Koupela health district, which is located
around 120km east of Ouagadougou. The second study was
conducted in one DU of the Health District of Bousse. Both
study sites have been extensively described elsewhere [4, 19,
20]. Malaria transmission is stable, with marked seasonality
in both sites. Transmission is intense during the rainy season
(June to October). The main malaria vectors are Anopheles
gambiae, Anopheles arabiensis, and Anopheles funestus.T h e
annual entomological inoculation rates range from 10 to
500 infective bites per individual. Plasmodium falciparum is
responsible for more than 90% of malaria infections.
2.2. Study Population. The study participants were pregnant
women who voluntarily consented to participate in trials of
malaria prophylaxis during pregnancy. They were encour-
aged to deliver at the health facility where the study samples
were collected for processing.
2.3. Clinical Procedures. Women delivering at the health
facility, after giving informed consent, were asked a standard
series of questions focused on sociodemographic charac-
teristics, history of fever, antimalarial drug use, and the
use of antimalarial chemoprophylaxis and bednets. Capillary
blood was obtained by ﬁngerstick for malaria blood ﬁlm
preparation. Placental blood ﬁlms were prepared by identi-
fying the maternal side of the placenta, wiping away excess
blood, cutting into the surface, and placing pooled blood
onto a slide. Umbilical cord blood samples were obtained by
wiping away excess blood from a clamped cord, piercing it
with a lancet, and placing a drop of expressed blood on a
slide.
A detailed clinical examination was done on each new-
born infant within 24 hours of delivery. Neonates were
weighted with an electronic digital scale (±10 grams) (Tanita
Corporation, Tokyo, Japan). The Dubowitz scoring system
was used to estimate gestational age, using ﬁndings from
physical and neurologic examinations. Scoring by APGAR
index was performed at delivery but was not recorded in this
study.
2.4. Lab Methods. All blood ﬁlms (maternal, placental,
and cord) were stained with Giemsa and examined for
parasites at the “Centre National de Recherche et de For-
mation sur le Paludisme” immunoparasitology laboratory
in Ouagadougou. For thick ﬁlms, parasites and leukocytes
were counted in the same ﬁelds until 500 leukocytes were
counted. Parasite densities were estimated using an assumed
leukocyte count of 8,000 leukocytes/µL. Parasite densities
were calculated according to the following formula: number
of parasites counted × 8000/number of leucocytes counted.
Thin ﬁlms were then used to determine species when thick
ﬁlms were positive. All slides were double-read by two
independent microscopists. If the ratio of densities from the
ﬁrst two readings was greater than 1.5 or less than 0.67, or
if fewer than 30 parasites were counted with a diﬀerence
of more than 10 parasites between the two readings, the
slide was evaluated a third time. The geometric mean of
the parasite density of the two most concordant results of
the three readings was taken as the ﬁnal result. When the
discordance was only in terms of positivity, the slide was also
evaluated a third time and the deﬁnitive result was based on
the majority verdict for positivity.
2.5. Deﬁnitions. Blood ﬁlm results were considered to be
positive if any asexual-stage parasites were identiﬁed and
negative if no parasites were seen in 100 high-power ﬁelds.
Prematuritywasdeﬁnedasagestationalage<37weeksas
estimated by Dubowitz examination.
We deﬁned low birth weight as a birth weight of <2,500g
with a gestational age ≥37 weeks.
2.6. Statistical Analysis. Data collected in the study ques-
tionnaire were veriﬁed, then double-entered, and validated
with EpiInfo, version 6.04 fr (Centers for Diseases Control
and Prevention, Atlanta, USA). Data were analyzed using
Epi-info and Stata 7.0. The analysis included data from
births of all enrolled participants who delivered at the study
centre clinic for whom data were available. Continuous,
normally distributed data were described by mean and
standard deviation and nonnormally distributed data by the
median or geometrical mean and range. Proportions were
comparedusingtheChi-squaretestandnormallydistributed
continuous variables were compared using Student’s t-test.
Statistical results were considered signiﬁcant, when the two-
sided P value was <0.05.Journal of Tropical Medicine 3
Table 1: Characteristics of enrolled women.
Gravidity
Characteristics 1 2 >2A l l
Age, median (years) 19.24 ±2.25 21.68 ±2.60 28.71 ±5.38 23.90 ±5.89
Mean gestational age (weeks) 38.16 ±4.24 38.79 ±3.79 39.02 ±3.59 38.66 ±3.89
Mossi ethnic group (%) 95.8 96.2 94.7 95.5
Sleeps under bednets (%) 22.8 28.1 19.4 22.4
Mother death (N)2 0 0 0
Pregnancy outcome
Stillbirth (N) 19 8 23 50
Miscarriage (N)8 3 7 1 8
Weight (g) 2,719 ±430 2,893 ±390 2,995 ±440 2,875 ±450
Number of live babies (N) 460 270 579 1309
LBW∗ (N/%) 111 (24.1%) 39 (14.4%) 57 (9.8%) 207 (15.8%)
LBW∗:l o wb i r t hw e i g h t .
2.7. Ethical Considerations. The study was discussed with
health authorities and local leaders to obtain their assent.
The study was reviewed and approved by the Burkina Faso
Ministry of Health ethical committee. Informed consent (by
signature or thumbprint) was obtained after the consent
document was read to the women in the local language. For
illiterate mothers, the informed consent discussion process
was witnessed by an impartial individual.
3. Results
3.1. Characteristics of Women at the Delivery Unit. In total,
1,374 women delivered at the health unit; 1,309 women
delivered singleton infants and provided data in the form
of peripheral blood smear, placental blood, and umbilical
cord blood. The proﬁle of enrolled women is summarized in
Table 1. Most of the women spoke Moore, a language indige-
nous to this region of Burkina Faso. The mean age (SD) of
the women was 23.90 ± 5.89years. The self-report indicated
that ownership and use of insecticide-impregnated materials
(bed nets and/or curtains) was reported by approximately
one-third of the women. The rate of use of insecticide-
impregnated materials (bed nets and/or curtains) was very
low in the study population. All of the women used drug
prophylaxis during their pregnancy (IPTp/SP or weekly
prophylaxis with chloroquine).
Primigravidae comprised 35% of the total sample size,
and primigravidae and secundigravida together made up
56% of the total sample size. The mean duration of gestation
was 38.66 ± 3.8 9w e e k s .T h em o d eo fd e l i v e r yo fb a b i e sw a s
spontaneous for 97.5% of the mothers.
Two women died during delivery as a consequence of
eclampsia. Other complications during the delivery included
peripartum haemorrhage, placental retention, and retropla-
cental haemorrhage. Fifty stillbirths (3.6%) and 18 (1.3%)
miscarriages occurred at the DUs.
The weight range of babies was 700g to 4,700g with a
mean weight of 2,875 ± 450g. Sixteen percent of the babies
presented low birth weight at delivery (Table 1).
3.2. Maternal Peripheral Parasitemia: Placental and Umbilical
Cord Blood Parasitemia. Over one-third of the women were
parasitaemic. Indeed, of the 1,309 pregnant women, Plas-
modium falciparum was detected in peripheral blood from
369(28.2%)ofthewomenatthetimeofdelivery.Overall,the
geometric mean of the maternal peripheral parasite density
was 1,106.47 (95% CI 871.58–1404.67) parasites/µL. Table 2
shows the prevalence of peripheral, placental, and umbilical
cord parasitemia. Plasmodiumfalciparumwasdetectedinthe
placentas of 255 (19.5%) women; 28.5% of these belonged to
primigravidae and 11.4% to multigravidae. The diﬀerence in
infection between the primigravidae and the multigravidae
was statistically signiﬁcant (P<0.0001). All of the women
received malaria prophylaxis during pregnancy.
Umbilical cord blood parasitemia with Plasmodium falci-
parum was detected in 18 (1.4%) babies, and the geometric
mean umbilical cord blood parasitemia was 315.69 (95% CI
87.02–1145.20) parasites/µL. Of these, 2.4% (11) belonged
to primigravidae and 0.5% (3) to multigravidae. Of the
18 babies with Plasmodium-falciparum-positive umbilical
cord blood parasitemia, 17 were positive for trophozoites
and 1 was positive for schizonts only. Both schizonts and
trophozoites were present in seven babies, and one newborn
had a triple-positive association (trophozoite + schizont +
gametocyte). Five newborns (27.8%) out of the 18 infected
with Plasmodium falciparum had low birth weight.
Out of 369 (28.2%) women with peripheral positive par-
asitemia, 211 (57.2%) had positive placental malaria and 14
(3.8%) had malaria parasites in the umbilical cord blood.
Eleven (5.2%) of the 211 (57.2%) women with positive pla-
cental smears for malaria had malaria parasites in the umbil-
ical cord blood. Of the 18 babies infected with Plasmodium
falciparum, 14 (77.8%) were born from mothers with4 Journal of Tropical Medicine
Table 2: The proportion of newborns with Plasmodium falciparum parasitemia in umbilical cord blood, placental parasitemia, and maternal
parasitemia, along with parasite density.
Gravidity
12 >2A l l
Peripheral parasitemia (%) 34.3 35.2 20.3 28.2








Negative peripheral parasitemia (%) 32.4 18.8 48.8 71.7
Peripheral parasitemia 1–999 (%) 30.9 29.5 39.6 11.4
Peripheral parasitemia 1,000–4,999 (%) 53.3 19.6 27.2 7.1
Peripheral parasitemia 5,000–9,999 (%) 52.5 22.5 25.0 3.1
Peripheral parasitemia ≥10,000 (%) 58.8 25.0 16.2 5.2
Placental parasitemia (%) 28.5 21.9 11.4 19.5








Negative placental parasitemia (%) 30.9 20.0 49.1 19.9
Placental parasitemia 1–999 (%) 46.5 26.4 27.1 10.1
Placental parasitemia 1,000–4,999 (%) 51.2 26.8 22.0 3.2
Placental parasitemia 5,000–9,999 (%) 50.0 29.2 20.8 1.9
Placental parasitemia ≥10,000 (%) 69.7 6.1 24.2 2.6
Umbilical cord parasitemia (%) 2.4 1.5 0.5 1.4








Negative umbilical cord parasitemia (%) 34.9 20.5 44.7 98.6
Umbilical cord parasitemia 1–999 (%) 61.5 15.4 23.1 1.0
Umbilical cord parasitemia 1,000–4,999 (%) 0.0 100 0.0 0.1
Umbilical cord parasitemia 5,000–9,999 (%) 0.0 0.0 0.0 0.0
Umbilical cord parasitemia ≥10,000 (%) 66.7 33.3 0.0 0.2
positive peripheral parasitemia. For two newborns with
Plasmodium falciparum infection, no peripheral or placental
infection was found in the mother. None of the babies with
cord blood positive for malaria had fever within the ﬁrst 24h
of life.
Thenumberofpregnantwomenwithperipheral,placen-
tal, and umbilical infection and high peripheral parasitemia
(>10,000 parasites/µL) decreased with increasing gravidity
(Table 2).
The combination of being born to a mother with
both peripheral and placental infection conferred a greater
likelihood of infection of the baby (61%). Being born with
only maternal peripheral infection reduced the likelihood
of having umbilical cord parasitemia (17%). There was
an association between umbilical cord blood infection and
maternal peripheral infection (P<0.001). Being born with
only placental infection reduced the rate of umbilical cord
parasitemia (11%). There was also an association between
umbilical cord blood infection and placental infection
(P<0.001) (Table 3).
Beingborntoamotherwithmaternalperipheralparasite
density ≥5,000 parasites/µL or placental parasite density
≥10,000parasites/µLconferredagreaterlikelihoodofumbil-
ical cord parasitemia (Table 3).
3.3. Risk Factors. We further examined the correlation
between risk factors and the presence or absence of umbilical
cord parasitemia to determine possible factors that might
aﬀect infection with malaria parasites in umbilical cord
blood. Univariate logistic regression analysis indicated that
being born with maternal parasitemia, being born with
maternal parasite density ≥ 5,000 parasites/µL, being born
with placental parasitemia, being born with placental par-
asite density between 1,000–4,999 parasites/µL, being born
with placental parasite density ≥10,000 parasites/µL, and
being born in a ﬁrst pregnancy were all associated with
the presence of umbilical cord blood parasitemia. Low
birth weight was not associated with umbilical cord blood
parasitemia (Table 3).
Low maternal peripheral and placental parasitemia,
prematurity, use of impregnated bednets, low birth weight,
and female sex were independent risk factors for infection in
the babies.Journal of Tropical Medicine 5
Table 3: Univariate logistic regression of risk factors associated with Plasmodium falciparum parasitemia in umbilical cord blood.
Proportion of newborns with
umbilical cord blood parasitemia
and the risk factor speciﬁed
Odds ratio 95% conﬁdence intervals P
Peripheral positive parasitemia 77.8% 9.24 3.02–28.28 <0.001
Peripheral parasitemia 1–999 22.2% 2.23 0.75–7.20 0.13
Peripheral parasitemia 1,000–4,999 11.1% 1.64 0.37–7.28 0.50
Peripheral parasitemia 5,000–9,999 22.2% 9.62 3.01–30.69 <0.001
Peripheral parasitemia ≥10,000 22.2% 5.29 1.69–16.52 0.004
Placental positive parasitemia 72.2% 10.74 3.79–30.42 <0.001
Placental parasitemia 1–999 16.7% 1.78 0.50–6.24 0.36
Placental parasitemia 1,000–4,999 22.2% 9.62 3.01–30.69 <0.001
Placental parasitemia 5,000–9,999 5.6% 3.13 0.40–24.56 0.27
Placental parasitemia ≥10,000 11.1% 4.91 1.08–22.28 0.03
Primigravid 61.1% 2.96 1.13–7.69 0.02
Prematurity (<37 weeks) 33.3% 1.58 0.52–4.25 0.36
ITN 33.3% 1.69 0.63–4.56 0.29
LBW∗ 27.8% 2.10 0.74–5.97 0.16
Female sex of infant 61.1% 1.78 0.68–4.63 0.33
LBW∗:l o wb i r t hw e i g h t .
Table 4: Multivariate logistic regression of risk factors, associated with Plasmodium falciparum parasitemia in umbilical cord blood.
Odds ratio 95% conﬁdence intervals P
Peripheral positive parasitemia 2.43 0.50–11.66 0.26
Peripheral parasitemia 5,000–9,999 3.71 0.92–14.98 0.06
Peripheral parasitemia ≥10,000 1.60 0.38–6.66 0.51
Placental positive parasitemia 3.30 0.73–14.87 0.11
Placental parasitemia 1,000–4,999 2.27 0.58–8.77 0.23
Placental parasitemia ≥10,000 0.95 0.15–5.69 0.95
Primigravid 1.91 0.70–5.21 0.20
On multivariate logistic regression, none of the seven
factors that were signiﬁcant on univariate logistic regression
remained signiﬁcant (Table 4).
4. Discussion
4.1. Low Levels of Umbilical Cord Parasitemia. This study
shows the burden of malaria in pregnant women at the
deliveryunitinamalaria-endemicareaofBurkinaFaso.This
investigation demonstrated the burden of malaria during
pregnancy. The maternal peripheral parasitemia rate found
in this study was 28.2%. This is similar to the rate reported
in other countries in sub-Saharan Africa [2, 21].
The prevalence of placental parasites was 19.5%. Previ-
ously reported prevalence rates of placental parasitemia in
Africa have been highly variable, ranging from 17.2% to 57%
[11, 22–24]. The placenta is a site for Plasmodium falciparum
sequestration. Many hypotheses, based on a systemic or
local failure of the immunological response to malaria, have
been proposed to explain the preference of the parasites for
replication in the placenta [25].
The malaria rate in umbilical cord blood was low in the
studypopulation,occurringin1.4%ofallnewborns,in5.2%
of babies born from mothers with peripheral and placental
malaria infection, and in 5.1% of babies born from women
with placental malaria infection only. Previously reported
rates from diﬀerent parts of Africa are highly variable,
ranging from 0% to 54% [11, 22, 24, 26, 27]. The low rate
in the present study, which is comparable to rates reported in
some previous manuscripts, could be explained by eﬀective
prevention of malaria during pregnancy. In fact, it has now
been proven that malaria parasites identiﬁed in cord blood
are acquired antenatally by transplacental transmission of
infected erythrocytes. The mechanisms underlying congen-
ital transmission, according to an earlier report, include
maternal transfusion into the fetal circulation either at the
time of delivery or during pregnancy, through direct pen-
etration through the chorionic villi, or through premature
separation of the placenta [28, 29]. Pregnant women, who
have received antimalarial treatment, should be able to
clear parasitemia to avoid umbilical cord transmission.
Immunity in the mother could also provide an explanation.
Transplacental transmission of malaria appears to occur6 Journal of Tropical Medicine
infrequently; it may be possible that after transplacental
transmission, some elements of immunity, acquired from
the mother, protect the infants from becoming infected
[24]. This resistance may reﬂect, among other things, the
physical barrier of the placenta to infected red cells, the
passive transfer of maternal antibodies, and/or the poor
environment aﬀorded by fetal erythrocytes for plasmodial
replication, due to their fetal hemoglobin composition and
low free-oxygen tension [28].
Some studies have found high rates of transplacental
malaria infection. The diﬀerence between those studies and
our report could be explained by several factors. First, the
high eﬃcacy of malaria prophylaxis during this study may
have allowed the women to clear their parasitaemia and
therefore prevent placental and transplacental transmission
of the infection to their babies. Second, our sole use of mi-
croscopy may have led to underdiagnosis, since this method
haslowersensitivitythanthenewermolecularmethods,such
as real-time PCR, used in other studies [22, 29]. Finally, it
might be that our numbers reﬂect the true prevalence of
infection, as compared with data collected during routine
services, in which lack of quality control of the reading of
smears could lead to an overestimation of the infection rate.
4.2. Risk Factors. Univariate analysis of the association of
risk factors with the presence or absence of umbilical cord
parasitemia revealed seven risk factors that was associated
with Plasmodium falciparum parasitemia in umbilical cord
blood. The presence of maternal peripheral parasitemia,
placental parasitemia, high-density peripheral parasitemia,
high-density placental parasitemia, and primigravid status
was associated with an increased risk of malaria parasitemia
in cord blood. However, in multivariate analysis, these
associations failed to reach statistical signiﬁcance.
Maternal peripheral blood parasitemia was associated
with umbilical cord blood parasitemia (OR = 9.24, P<
0.001). Four cases of umbilical cord blood parasitemia oc-
curred in pregnancies not complicated by maternal periph-
eral malaria infection.
There were also associations between placental and cord
blood parasitemia (OR = 10.74, P<0.001), and between
cord blood/placental and maternal peripheral parasitemia.
Five cases of umbilical cord blood parasitemia occurred in
pregnancies not complicated by placental malaria infection.
Only two newborns had mothers with neither peripheral
malaria infection nor placental malaria infection. Earlier
studies of transplacental malaria reported these associations
[11, 18, 24, 30]. A strong association between placental
malaria and umbilical cord blood parasitemia has been
reported, and this was suggested to be responsible for
congenital malaria. However, whether the presence of Plas-
modiumfalciparummalariaparasitesinumbilicalcordblood
denotes infection acquired antenatally or contamination
with infected maternal blood at delivery is not clear [15].
Theseassociationssuggestthatclearingmaternalandplacen-
tal parasitemia with eﬀective antimalarial drugs before deliv-
erycouldpreventtransplacentaltransmissionofparasitemia.
The density of maternal peripheral parasitemia (>5,000
parasites/µL)wasanimportantdeterminantofthelikelihood
of umbilical cord blood parasitemia (OR = 5.29, P = 0.004).
The density of placental parasitemia (>10,000 parasites/µL)
was also an important determinant of the likelihood of
umbilical cord parasitemia (OR = 4.91, P = 0.03).
High density parasitemia seems to facilitate umbilical cord
infection. Conversely, previous reports, showing low rates
of transplacental transmission of malaria, suggest that the
placental barrier is very eﬀective in the case of very low
malaria parasite density [22].
Finally, univariate analysis showed that being born from
a ﬁrst pregnancy was also linked to umbilical cord blood
parasitemia (OR = 2.96, P = 0.02).
5. Conclusions
Our data indicate that the rate of mother-to-child trans-
mission of malaria, deﬁned as positive umbilical cord blood
parasitemia, appears to be low. Clinicians are therefore
advised to investigate other aetiologies of fever in neonates.
The low level of parasitaemia in cord blood suggests that
contamination probably occurs during the labour period.
Maternal, placental, and high density parasitemia were all
associated with umbilical cord parasitemia. Prevention of
malaria during pregnancy with eﬀective antimalarial drugs
should reduce the risk of infection for newborns.
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